Compare GSRF & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GSRF | SRZN |
|---|---|---|
| Founded | 2023 | 2015 |
| Country | United States | United States |
| Employees | N/A | 59 |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 298.8M | 349.0M |
| IPO Year | 2025 | 2020 |
| Metric | GSRF | SRZN |
|---|---|---|
| Price | $10.27 | $23.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $48.40 |
| AVG Volume (30 Days) | 91.2K | ★ 874.0K |
| Earning Date | 01-01-0001 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,477,000.00 |
| Revenue This Year | N/A | $208.89 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $184.52 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.96 | $11.39 |
| 52 Week High | $10.27 | $37.83 |
| Indicator | GSRF | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 71.86 | 46.39 |
| Support Level | $10.15 | $17.88 |
| Resistance Level | N/A | $24.88 |
| Average True Range (ATR) | 0.00 | 3.65 |
| MACD | -0.00 | -0.40 |
| Stochastic Oscillator | 75.00 | 9.61 |
GSR IV Acquisition Corp is a blank check company.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).